Table 1.
Oxymetric studies linking hypoxia and radiation therapy outcome.
Oxymetric technique | Animal studies | Reference | Clinical studies | Reference | Cross-validation with quantitative oxymetric methods? | Reference |
---|---|---|---|---|---|---|
Eppendorf electrodes | C3H mammary tumors: significant difference in local tumor control between the fraction of hypoxic values (<2.5 mmHg) and less hypoxic tumors | (36) | Prostate cancer study (n = 57): 8-year survival is 78% for moderately hypoxic tumors and 46% for severe hypoxic tumors | (16) | n.a. | |
Head and neck cancer study (n = 35): 2-year locoregional control is two times lower for hypoxic tumors (i.e., with 15% of readings <2.5 mmHg) | (15) | |||||
PET 18F-MISO | FaDu hSCC xenografts: prognostic value of pretreatment 18F-MISO hypoxic volume; SUVmax was not associated with local control | (25) | 5 head and neck studies (n = 45; 73; 12; 17; 15) | (21, 24, 26, 27, 29) | Mixed results | (23) |
|
Lack of correlation with Eppendorf measurements in head and neck tumors | |||||
PET 18F-FAZA | Rhabdomyosarcoma: lower uptake linked to better local tumor control at 90 days post-irradiation | (36) | Head and neck cancer study: DAHANCA trial (n = 40), high tumor uptake is correlated to lower disease-free survival | (38) | Positive results | (38) |
Validated with EPR oximetry in the preclinical setting (rat rhabdomyosarcomas) | ||||||
9L glioma and rhabdomyosarcoma: significant correlation between 18F-FAZA T/B and tumor growth delay | (37) | |||||
PET 18F-FETNIM | 1 head and neck cancer study (n = 21) | (21) | NO (but compared with other nitroimidazoles) | (44, 45) | ||
2 lung cancer studies (n = 26; 32) |
|
|||||
1 cervical cancer study (n = 16) | ||||||
1 esophageal cancer study (n = 28) | ||||||
High fractional hypoxic volumes, uptake, or baseline SUVmax correlated with PFS, OS, or clinical response | ||||||
PET 60CU-ATSM | Canine sinonasal tumors: lack of correlation between Cu-ATSM uptake and outcome | (51) | 3 cervical cancer studies (n = 14; 15; 38) | (21, 48–50) | Mixed results | (40, 57–63) |
2 head and neck cancer studies (n = 15; 11) |
|
|||||
3 lung cancer studies (n = 19; 22; 7) | Potential link with tumor redox status | |||||
1 rectal cancer study (n = 19) | ||||||
|
||||||
Dynamic contrast-enhanced magnetic resonance imaging | Melanoma xenografts: low ktrans is correlated with increased radioresistance | (78) | Cervical cancer study: ktrans and ABrix parameters correlated with poor outcome | (80) | Mixed results | (82) |
| ||||||
Cervical cancer xenografts: basal ktrans correlated to the outcome of RT; skewness (heterogeneity) in ktrans distribution correlated with poorer outcome | (79) |
|
(83, 84) | |||
Mouse fibrosarcoma: none of the tested DCE parameters (ktrans, vp, Kep, % of perfused voxels) were related to RT outcome | (69) | |||||
G3H prolactinomas (rats) | (100) | Cervical cancer study: basal was predictive for RT response | 90 | Mixed results | (96–98) | |
RIF-1 fibrosarcomas (mice) |
|
|||||
was predictive for a transient reduction in tumor size; low baseline was linked to a small reduction in tumor size | ||||||
R1–T1 of water protons | Dunning R3327-AT1 rat prostate | (92) | Mixed results | |||
A large increase in R1 response to hyperoxic challenge was linked to a longer tumor growth delay after radiation therapy | No study addressing potential correlations between R1–T1 and quantitative pO2 measurements | |||||
R1–T1 of lipid protons | 9L glioma | (101) | Mixed results | (101, 123) | ||
Water and lipids T1 are less predictive of RT outcome than in this model |
|
|||||
Combined R1 and MRI | Dunning rat prostate tumors | (121) | ||||
Useful factors to predict tumor response to hypofractionation | ||||||
EPR oximetry | C6 and 9L glioma | (151) | ||||
pO2 assessed after a first course of RT was a prognostic indicator of differential response to RT between the two glioma models | ||||||
TLT and FSaII syngeneic tumors | (69, 76, 130, 132, 136–146, 148) | |||||
pO2 assessed during/after administration of treatments able to alleviate tumor oxygenation was predictive of the outcome of RT when administered during this window of reoxygenation |